Intrinsiqq
Greenland Mines Ltd logo

Greenland Mines Ltd Insider Trading

GRML

Compare
Last 12 months

Insiders bought 468K and sold 40K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Riad Hussein El-Dada sold 40K on Jun 25, 50% of their stake, outside a plan.

Net open-market
+428K
4 buys · 1 sale
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
3 / 1
executives and directors
Last open-market buy
Aug 2026
Aug 25, 2026

Get an email when GRML's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 1No plan
    Riad Hussein El-Dada
    Other · sold 3,500 at $9.35
    33K
    100% of stake
  • Aug 25
    Jeff Leblanc
    Chief Financial Officer · bought 14,000 at $9.72
    136K
    15% of stake
  • Jul 22
    Jason David Sawyer
    Director · bought 240,000 at $0.23
    55K
    New position
  • Jul 20
    Jon McGarity
    Director · bought 140,000 at $0.18
    25K
    34% of stake
  • Jul 16
    Jeff Leblanc
    Chief Financial Officer · bought 1,400,000 at $0.18
    252K
    41% of stake
  • Jun 25No plan
    Riad Hussein El-Dada
    Director · sold 175,000 at $0.23
    40K
    50% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch GRML, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with GRML

CompareIntrinsic value
BCABBioAtla, Inc.
$1.55+20.16%0
TILInstil Bio, Inc.
$5.23-5.77%10
IVVDInvivyd Inc.
$0.41-7.47%10
LXEOLexeo Therapeutics Inc.
$2.96+0.34%10
ELOXEloxx Pharmaceuticals, Inc.
$10.75+0.94%20
CLDICalidi Biotherapeutics Inc.
$0.48-5.45%19
INBXInhibrx Biosciences, Inc.
$68.97-7.21%18
CRISCuris Inc.
$0.44-7.21%35

Spot a number that looks wrong? Check it in GRML's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing GRML

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.